Table 5.
Specific binding site for a particular drug ligand for a specific protein with binding energy less than −7.5 kcal/mol. Binding site was compared with active site and common amino acids are listed.
Sr. No. | Active site | Name of the drug with binding energy in –Kcal/mol | Binding with drug with binding energy |
---|---|---|---|
1. |
6Y84 (Mpro/3CLpro (Main protease of SARS-CoV-2)) MET6, ALA7, PHE8, PRO9, VAL104, ILE106, GLN107, PRO108, GLY109, GLN110, THR111, GLN 127, PRO132, ASN151, ILE152, ASP153, TYR154, CYS156, SER158, ILE200, THR201, VAL202, ASN203, GLU240, PRO241, ASP245, HIS246, ILE 249, GLU290, PHE291, THR292, PRO293, PHE294, ASP295, ARG298, GLN299, GLY302, VAL303, THR304 |
Lopinavir (−9.9) GLN 127, GLU290, PHE291 |
![]() |
Remdesivir (−9.4) GLN 127, GLU290, PHE291 |
![]() |
||
Eriodictyol (−8.8) | ![]() |
||
GLN 127, GLU290 | |||
Ritonavir (−8.7) GLN 127, GLU290, PHE291 |
![]() |
||
Ribavirin (−8.2) GLN127, GLU290 |
![]() |
||
Pemirolast (−8.2) GLN127, GLU290 |
![]() |
||
Mycophenolic acid (−8) GLN127, GLU290 |
![]() |
||
Hydroxychloroquine (−7.9) GLN 127, GLU290, PHE291 |
![]() |
||
Chloroquine (- 7.8) GLU290, PHE291 |
![]() |
||
2 |
6VXS (ADP ribose phosphatase of NSP3 from SARS CoV-2) ALA21, ASP22, ILE23, VAL24, ALA38, ALA39, ASN40, LYS44, GLY46, GLY47, GLY48, VAL49, ALA50, ALA52, VAL95, GLY97, PRO125, LEU126, LEU127, SER128, ALA129, GLY130, ILE131, PHE132, PRO136, ALA154, VAL155, PHE156, ASP157, LEU160 |
Lopinavir(-7.9) LYS44 |
![]() |
Eriodictyol (−7.8) ALA38, ASN40, GLY46, GLY47, GLY48,VAL49, ALA50, PRO125, LEU126, LEU127, SER128, ALA129, ILE131, PHE132 |
![]() |
||
Pemirolast (−7.6) LYS44 |
![]() |
||
3 |
6M03 (COVID-19 main protease in apo form) CYS 22, GLY23, THR24, THR25, THR26, LEU27, HIS41, VAL42, ILE43, CYS44, THR45, SER46, MET49, LEU50, LYS61, PHE140, LEU141, ASN142, GLY143, SER144, CYS145, HIS163, HIS164, MET165, GLU166, LEU167, PRO168, ARG188, GLN189, THR190, GLN192 |
Remdesivir (−7.8) | ![]() |
Pemirolast (−7.7) | ![]() |
||
4 |
2GHV (SARS spike protein receptor binding domain) Chain E PHE361, SER362, THR363, PHE364, LYS365, CYS366,TYR367, GLY368, GLY391, ASP392, VAL394, ARG395, ILE397, ALA398, PRO399, GLN401, ASP414, PHE416, VAL420, ALA422, ILE489, GLY490, TYR494 Chain C PHE361, SER362, THR363, PHE364, LYS365, CYS366, TYR367, GLY368, GLY391, ASP392, VAL394, ARG395, ILE397, ALA398, PRO399,GLY400, GLN401, ASP414, PHE416, VAL420, ALA422, ILE489, GLY490, TYR494 |
Ritonavir (−7.6) Chain E PHE361, SER362 Chain C GLY368 |
![]() |
5 |
6VSB C (Spike glycoprotein) Active site contains many amino acids |
Eriodictyol (−7.6) ASN544, VAL576, PHE543, LEU546, PHE565, ALA522, ARG577, PRO521, PRO579, GLN564 |
![]() |
6 |
6W75A (NSP10 – NSP16 Complex from SARS-CoV-2) ASN6841, LYS6844, TYR6845, HIS6867, PHE6868, GLY6869, ALA6870, GLY6871, SER6872, ASP6873, PRO6878, GLY6879, SER6896, ASP6897, LEU6898, ASN6899, ASP6900, PHE6901, GLY6911, ASP6912, CYS6913, ASP6928, MET6929, TYR6930, ASP6931, PRO6932, LYS6933, GLY6946, PHE6947, LYS6968 |
Eriodictyol (−7.8) | ![]() |
7 |
6W75C (NSP10 – NSP16 Complex from SARS-CoV-2) ASN6841, LYS6844, TYR6845, HIS6867, PHE6868, GLY6869, ALA6870, GLY6871, SER6872, ASP6873, PRO6878, GLY6879, SER6896, ASP6897, LEU6898, ASN6899, ASP6900, PHE6901, GLY6911, ASP6912, CYS6913, ASP6928, MET6929, TYR6930, ASP6931, PRO6932, LYS6933, GLY6946, PHE6947, LYS6968 |
Remdesivir (−7.6) | ![]() |
Eriodictyol (−7.5) | ![]() |
||
8. | 6W75D (NSP10 – NSP16 Complex from SARS-CoV-2) ALA4273, VAL4274, ASP4275, ALA4276, ALA4277, TYR4329, ILE4334, ASP4335, HIS 4336, PRO4337 | Eriodictyol (−7.5) TYR4329, HIS 4336, PRO4337 | ![]() |
9 |
6M18B (Angiotensin-converting enzyme 2 (ACE2) receptor) SER623, LYS625, SER626, ALA627, LEU628, GLY629, ASP630, LYS631, ARG678, ARG705, ARG708, SER709, ASN712, ASP713, ARG716, LEU717, ASN718, ASP719, ASN720, SER721, GLU723, ILE727, GLN728, PRO729, THR730, LEU731, GLY732, PRO733, PRO734, ASN735, GLN736, PRO737, PRO738, VAL739, ILE741, ILE744, VAL745, VAL748, VAL749, VAL752, ILE753, VAL755, GLY756, VAL758, ILE759, LEU760, PHE762, THR763, ARG766, ASP767, ARG768, SER623 |
Lopinavir (−8.6) | ![]() |
Ritonavir(-8.2) | ![]() |
||
Remdesivir (−8.2) | ![]() |
||
Eriodictyol (−7.5) | ![]() |
||
10 |
6M18D (Angiotensin-converting enzyme 2 (ACE2) receptor) SER623, LYS625, SER626, ALA627, LEU628, GLY629, ASP630, LSY631, ARG678, ARG705, ARG708, SER709, ASN712, ASP713, ARG716, LEU717, ASN718, ASP719, ASN720, SER721, GLU723, ILE727, GLN728, PRO729, THR730, LEU731, GLY732, PRO733, PRO734, ASN735, GLN736, PRO737, PRO738, VAL739, ILE741, ILE744, VAL745, VAL748, VAL749, VAL752, ILE753, VAL755, GLY756, VAL758, ILE759, LEU760, PHE762, THR763, ARG766, ASP767, ARG768 |
Lopinavir (−8.9) | ![]() |
Ritonavir (−8.1) | ![]() |
||
Remdesivir (−7.7) | ![]() |